© 2026 CellCarta - All rights reserved.
October 12th, 2026
13:00 - 18:00
Hyperion Hotel
Basel, Switzerland
13:00-13:20
Welcome & Networking
Immune Monitoring
• Flow cytometry (conventional & spectral)
• Mass cytometry (CyTOF)
• Cytometry data analysis with CellEngine software
CellCarta supports highly customized biomarker strategies and large-scale global studies across the full biomarker continuum — from translational research through clinical development and companion diagnostic (CDx) advancement. Connect with our team to explore how our owned laboratories across North America, Europe, Australia, and China can deliver globally consistent execution from a single, integrated partner.
CellCarta supports highly customized biomarker strategies and large-scale global studies across the full biomarker continuum — from translational research through clinical development and companion diagnostic (CDx) advancement. Connect with our team to explore how our owned laboratories across North America, Europe, Australia, and China can deliver globally consistent execution from a single, integrated partner.
• Flow cytometry (conventional & spectral)
• Mass cytometry (CyTOF)
• Cytometry data analysis with CellEngine software
Immune Monitoring
Histopathology
• IF/IHC (multiplex)
• ISH
• Spatial biology
• Pathology & digital pathology
Genomics
• NGS
• WES, WGS
• RNAseq
• Digital and quantitative PCR
• Single-cell sequencing
• Spatial transcriptomic
Proteomics
• Immunoassays (Olink, MSD, ELLA)
• Mass Spectrometry
Logistics
• Sample logistics
• Kitting & lab manuals
• Biorepository services
• Global PBMC processing network
Histopathology
• IF/IHC (multiplex)
• ISH
• Spatial biology
• Pathology & digital pathology
Genomics
• NGS
• WES, WGS
• RNAseq
• Digital and quantitative PCR
• Single-cell sequencing
• Spatial transcriptomic
Proteomics
• Immunoassays (Olink, MSD, ELLA)
• Mass Spectrometry
Logistics
• Sample logistics
• Kitting & lab manuals
• Biorepository services
• Global PBMC processing network
PBMC Processing
Same-day PBMC processing following robust SOPs across labs in NA, EU, Australia, and China.
PBMC Processing
Same-day PBMC processing following robust SOPs across labs in NA, EU, Australia, and China.
Julie Mutert
Todd Chermak
President
Elizabeth Ross
Director of Scientific Business Development
Tumor-Informed MRD Workflows: From Whole Genome to Targeted Panels
Pieter Mestdagh
Executive Director, Genomics Scientific Business Lead
Céline Vandamme
13:20-13:50
Regulatory Support from Your CRO: IVDR & Health Institution Exemption with Julie Mutert, Associate Director Global Regulatory Affairs
13:50-14.20
Novel Operating Models for Companion Diagnostics (CDx) with Todd Chermak, President
14:20-14.40 Coffee Break
14.40-15.10
Spatial Biology with mIF: Revealing Tissue Architecture and Biomarker Landscape
Technology implementation, including the Lunaphore COMETTM, in a clinical environment with Elizabeth Ross, Director, Scientific Business Development, in collaboration with BioTechne
15.10 - 15.40
Tumor-Informed MRD Workflows: From Whole Genome to Targeted Panels with Pieter Mestdagh, Executive Director, Genomics Scientific Business Lead
15.40-16.00 Coffee Break
16:00-16.30
Following the B-Cell Journey: From Depletion to Reconstitution in Autoimmune Trials with Céline Vandamme, Director, Scientific Business Development
16.30-17:00
Biomarker Working Session: Open discussion with CellCarta experts and biotech colleagues
17.00-18:00 Networking
13:00-13:20
Welcome & Networking
13:20-13:50
Regulatory Support from Your CRO: IVDR & Health Institution Exemption with Julie Mutert, Associate Director Global Regulatory Affairs
13:50-14.20
Novel Operating Models for Companion Diagnostics (CDx) with Todd Chermak, President
14:20-14.40
• Coffee Break
14.40-15.10
Spatial Biology with mIF: Revealing Tissue architecture and Biomarker landscape
Technology implementation, including the Lunaphore COMETTM, in a clinical environment with Elizabeth Ross, Director, Scientific Business Development, in collaboration with BioTechne
15.10 - 15.40
Tumor-Informed MRD Workflows: From Whole Genome to Targeted Panels with Pieter Mestdagh, Executive Director, Genomics Scientific Business Lead
15.40-16.00
Coffee Break
16:00-16.30
Following the B-Cell Journey: From Depletion to Reconstitution in Autoimmune Trials with Céline Vandamme, Director, Scientific Business Development
16.30-17:00
Biomarker Working Session
Open discussion with CellCarta experts and few biotech colleagues
17:00 - 18.00
Networking
PBMC Processing
Same-day PBMC processing following robust SOPs across labs in NA, EU, Australia, and China.
PBMC Processing
Same-day PBMC processing following robust SOPs across labs in NA, EU, Australia, and China.
Julie Mutert
Julie Mutert
"CellCarta’s project managers are supportive and attentive — they coordinate with your data team, CRO/CRAs, and other vendors as needed. They don't wait for us as the sponsor to bring issues up; they bring concerns to our attention and come prepared with resolution options.”
Lead Outsourcing Director, Biopharma
Todd Chermak
President
Elizabeth Ross
Director of Scientific Business Development
Tumor-Informed MRD Workflows: From Whole Genome to Targeted Panels
Pieter Mestdagh
Executive Director, Genomics Scientific Business Lead
Céline Vandamme
“CellCarta was extremely helpful with the data analysis: great shout out to the data analysis team! The team in MTL was super fast and super professional!”
Biopharma Partner
“CellCarta was able to present a proposal in less than a week and they were ready to contract to get kits to our sites as soon as possible. They offered expedited start up without breaking the bank on costs to get the database and lab manual ready for review and sign off faster than any other central lab I've come across.”
Lead Outsourcing Director, Biopharma
Todd Chermak
Elizabeth Ross
Pieter Mestdagh
Céline Vandamme